InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-09-23 | Valerie Hoyle(D-OR04) | house | Sale | $1,001 - $15,000 |
No financial data available for UCBJY.
Company may not file with SEC or CIK is unresolved.
Is It Too Late To Consider UCB (ENXTBR:UCB) After A 195% Three Year Surge?
A Look At UCB (ENXTBR:UCB) Valuation After Neurology Conference Data And Real World Results
Belgian pharma UCB to buy U.S.-based Neurona for up to $1.15B
UCB (UCBJY) Upgraded to Strong Buy: Here's What You Should Know
UCB S.A. Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Technology Initiatives, ICT, Partnerships, Investments & Acquisitions, Network Map
UCB - Convening Notice to the General Meeting of the Shareholders 2026
PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors
AbbVie’s Skyrizi beaten by UCB’s Bimzelx in psoriatic arthritis
UCB SA (UCBJF) (FY 2025) Earnings Call Highlights: Record Growth and Strategic Investments ...
UCB SA (UCBJY) Q4 2025 Earnings Call Transcript
UCB SA 2025 Q4 - Results - Earnings Call Presentation
UCB SA Non-GAAP EPS of €9.99, revenue of €7.74B; introduces FY26 outlook